Items Tagged ‘antibodies’
February 14, 2022
Mayo Clinic Proceedings: In the Limelight, February 2022
By Advancing the Science contributor 
Mayo Clinic publishes two peer-reviewed journals, accepting original research and related content from investigators around the world. Advancing the Science shares stories about research published in Mayo Clinic Proceedings, its sister journal, and many other English-language journals. In order to gain more visibility for all the research covered by Mayo’s premier journal, we are reprint ‘In The Limelight’ […]
Tags: antibodies, cardiovascular disease, COVID-19, diabetes, Doug Challener, John (Jack) O'Horo, Leigh Speicher, Mayo Clinic Proceedings, obesity, population health, Raymund Razonable, stroke
August 10, 2021
Mayo Clinic Research in the news — 8/9/2021
By Advancing the Science contributor
COVID-19 has once again taken almost all the headlines. However, research and expertise across the vastness of medicine still continues. Those stories are at the top — dancing after menopause, hemp seeds for inflammation, ‘brain orgasms’, and more. Then read on for the latest understanding in why the delta variant spreads even among vaccinated people, […]
Tags: Abinash Virk, Ala Dababneh, Angela Dispenzieri, antibodies, arthritis, Arya Mohabbat, cancer, cardiology, chemotherapy, COVID-19, dementia, Devang Sanghavi
July 26, 2021
Mayo Clinic Research in the news — 7/26/2021
By Advancing the Science contributor
Mayo Clinic expertise has a consistent footprint in the news in 2021. This week’s topics include data security and interoperability; some lesser discussed COVID-19 related topics: language development, booster vaccines for immunocompromised individuals, portable air filters; as well as early onset dementia, and the need for diversity among bone marrow donors. Vaccines are highy unlikely […]
Tags: Aaron Krych, acute kidney injury, Ahmad Nassr, antibodies, arthritis, artificial intelligence, big data, biomarkers, bone marrow transplant, Brian Weinshenker, Bruce Johnson, Bruce Sutor
June 28, 2021
Mayo Clinic Research in the news — 6/28/2021
By Advancing the Science contributor
Vaping, medical AI, the challenges of serving patients with cancer and diabetes, current COVID-19 vaccine and long haul information, and a wide selection of other topics are covered in this week’s news. The Vaping Study You Haven’t Heard Of Slate, 6/25/2021 A report from the Mayo Clinic looked at 70,000 patients and found no link […]
Tags: Alzheimer's disease, antibodies, artificial intelligence, Ashley Wentworth, autoimmune disorder, Barbara Barry, bioethics, biomedical ethics, cancer, cardiovascular disease, Center for Regenerative Medicine, COVID-19
May 14, 2021
Mayo Clinic Proceedings: In the Limelight, May 2021
By Advancing the Science contributor
Mayo Clinic publishes two peer-reviewed journals, accepting original research and related content from investigators around the world. Advancing the Science shares stories about research published in Mayo Clinic Proceedings, its sister journal, and many other English-language journals. In order to gain more visibility for all the research covered by Mayo’s premier journal, we are going to reprint ‘In […]
Tags: AFib, Andrew Tseng, antibodies, atrial fibrillation, cardiology, COVID-19, epidemiology, FDA, immune system, Karl Nath, Mayo Clinic Proceedings, multiple chronic conditions
February 16, 2021
Mayo Clinic Research in the news — 2/15/2021
By Advancing the Science contributor
Mayo Clinic research and faculty were highlighted in a range of articles over the last week. Headlines and links below to stories on research collaborations and expansions, as well as specific disease advancements, and all the latest COVID-19 news and information. Ionic liquid formulation can uniformly deliver chemotherapy to tumors while destroying cancerous tissue in […]
Tags: aging, Alzheimer's disease, antibodies, cancer, CAR-T cell therapy, COVID-19, diabetes, gastrointestinal cancer, heart failure, hereditary diseases, News of the Week, opioids
December 21, 2020
Mayo Clinic Research in the news — 12/21/2020
Mid-December, many people are focused on activities and information related to the holidays. The news media are no exception, with very little attention paid to health care research, unless it has a holiday hook. As a result, news is slim about various advancements in understanding, treating and preventing disease. Nonetheless, Mayo Clinic Research and researchers […]
Tags: ADHD, antibodies, artificial intelligence, Barrett's esophagus, Brian Lacy, cancer, cardiovascular disease, clinical trials, COVID-19, data science, epidemiology, esophageal cancer
November 23, 2020
Mayo Clinic Research in the news — 11/23/2020
There were all sorts of different things in the news this week, but perhaps the most heartening was the news from Dr. Anthony Fauci and our own Gregory Poland, M.D., that Santa Claus and the elves are practicing safe behaviors and COVID-19 won’t stop Christmas from arriving. Read on for excerpts from this and other […]
Tags: Amir Lerman, Andrew Badley, Anna Subramaniam, antibiotic, antibodies, anxiety, autism, cardiovascular medicine, clinical research, COVID-19, depression, DNA
October 15, 2020
The latest on testicular cancer-associated KLHL11 encephalitis
By Advancing the Science contributor
Divyanshu (Div) Dubey, M.B.B.S., a Mayo Clinic physician and researcher, who holds a dual appointment in neurology, and laboratory medicine and pathology, recently led a multi-institutional research study to advance understanding of KLHL11 encephalitis or testicular cancer-associated paraneoplastic encephalitis. Published in JAMA Neurology, the paper builds on the work Dr. Dubey and other members of […]
Tags: antibodies, brain, collaboration, Department of Laboratory Medicine and Pathology, Divyanshu Dubey, DNA, encephalitis, neurology, testicular cancer
October 9, 2020
Mayo Clinic Research in the news — 10/9/2020
While Mayo Clinic has long been known as a clinical powerhouse, only more recently has the world actively noted our Research and Education shields. This increased awareness has led to visibility for both our research and our researchers in national and international news and education forums. In the past week, they have been featured in […]
Tags: Alzheimer's disease, amnesia, antibodies, Barry Borlaug, biomarkers, biostatistics, blood pressure, Bobbi Pritt, clinical trials, Colin West, community engagement, Cornelius Thiels